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A neutral compound Re(CO)3(L) (L: 2-((2-(2,6-diethylphenylamino)-2-oxoethyl)(2-ethoxy-2-oxoethyl)amino)acetic acid, an
IDA analogue) has been synthesized and evaluated for in vitro imaging probes of β-amyloid (Aβ)a g g r e g a t e s .R e s u l t so fX -
ray measurement of Re(CO)3(L) demonstrated that the coordination mode of Re(CO)3(L) was diﬀe r e n tf r o mt h a to fc l a s s i c a l
Re/Tc(I) (tricarbonyl)-IDA analogues; the structure of Re(CO)3(L) was conﬁrmed by means of infrared spectrum, HPLC-UV,
TOF MS, and X-ray measurements (Cambridge Crystallographic Data Centre number is 732731): monoclinic P21/c, a = 15.6636
(12) ˚ A, b = 10.9360 (8) ˚ A, c = 27.756 (2) ˚ A, α = 90.000 (0)◦, β = 90.783 (5)◦, γ = 90.000 (0)◦,a n dZ = 8. The binding
aﬃnity for β-amyloid plaques was assessed by in vitro binding assay using preformed synthetic Aβ(1–40) aggregates. The neutral
compound Re(CO)3(L) showed binding aﬃnity to Aβ aggregates at micromolar level by ﬂuorescence spectroscopy, and this work
will encourage for further exploration of imaging agents labeled by 99mTc(CO)3
+ center as probes for β-amyloid plaques in vivo.
Copyright © 2009 Yang Yang et al. This is an open access article distributed under the Creative Commons Attribution License,
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
1.Introduction
Alzheimer’s disease (AD) is a neurodegenerative disease
characterized by dementia, cognitive impairment, and mem-
ory loss, and so far the only deﬁnitive conﬁrmation of AD
is universally accepted by histopathologic examination of
extracellular amyloid plaques comprised of amyloid-beta
(Aβ) aggregates and intracellular numerous neuroﬁbrillary
tangles in the postmortem brain; furthermore, formation of
Aβ aggregates in the brain became the hallmark feature on
early pathogenesis of AD before another alternative hypoth-
esis emerged [1]. Several compounds have been selected to
be radiolabeled and used in the noninvasive detection of
Aβ aggregates by imaging techniques of positron emission
tomography (PET) and single photon emission-computed
tomography (SPECT); in addition, these representative Aβ-
detectors were derivatives of congo red, thioﬂavin, stil-
bene, and DDNP (6-dialakylamino-2-naphthylidene), such
as 11C-PIB, 125I-TZDM, 11C-SB-13, and 18F-FDDNP [2].
However, the progress of SPECT imaging agents labeled
by techenetium-99m center fell behind, because of their
low rates of penetration through the blood-brain barrier
(BBB) [3]. Iminodiacetic acid (IDA) derivatives EHIDA
labeled by 99mTc(CO)3 h a sb e e ns t u d i e do np h y s i c o c h e m i c a l
properties and biological evaluation [4, 5], but the structure
oftechnetium(I)-tricarbonylEHIDAhasnotbeenidentiﬁed.
In this paper, we reported the synthesis of Re(CO)3(L)
(L is esteriﬁed EHIDA), and the novel crystal structure
of this complex was determined by X-ray measurement:
the coordination mode of Re(CO)3(L) was diﬀerent from
that of classical Re/Tc(I) (tricarbonyl)-IDA derivatives. The
neutral compound Re(CO)3(L) showed binding aﬃnity to
Aβ aggregates in vitro at micromolar level by ﬂuorescence
spectroscopy.
2. Experimental
2.1. Materials and Preformed Synthetic Aβ(1–40) Aggregates.
Aβ(1∼40) peptide was purchased from Shang Hai “Supermed”
Trade Limited Company. Re(CO)5Br, Thioﬂavin T, Phos-
phate Buﬀer Solution (PBS, pH = 7.4), and EDTA
were purchased from Sigma-Aldrich Chemical Company.
Other chemicals were all purchased from Beijing Chemical
Reagents Company. EHIDA was synthesized according to the
previous method [6].2 Bioinorganic Chemistry and Applications
Table 1: Summary of crystal data of Re(CO)3(L).
Re(CO)3(L)
Empirical formula C21H19N2O8Re
Formula weight 613.58
Temperature 296 (2)K
Wavelength 0.71073A
Crystal system, space group Monoclinic, P2(1)/c
Unit cell dimensions
A(˚ A) 15.6636 (12)
B(˚ A) 10.9360 (8)
C(˚ A) 27.756 (2)
α(◦) 90.000 (0)
β(◦) 90.783 (5)
γ(◦) 90.000 (0)
Unit cell Volume(˚ A3) 4754.1 (6)
Z, Calculated density 8, 1.715mg/m3
Absorption coeﬃcient(mm−1) 5.158mm−1
F(000) 2384
Crystal size 0.34 ×0.07 ×0.05mm
Completeness to theta = 25.46 99.5%
Goodness-of-ﬁt on F2 1.007
Final R indices [I>2σ(I)]; R1, wR2 0.0324, 0.0729
R indices (all data); R1, wR2
a 0.0619, 0.0838
aR1 =

(|Fo|−|Fc|)/

|Fo|; wR2 = [

[w(F2
o −F2
c )
2]/

[w(F2
o)
2]]
1/2
.
Formation of Aβ(1∼40) aggregates. Aβ(1∼40) aggregates
(Figure 1(a)) were prepared according to the method pub-
lished previously [7]. 1mg of brief Aβ(1∼40) and 20μL EDTA
solution (1mM) were dissolved in 2mL PBS (pH = 7.4), and
the mixture was mixed with a magnetic stir bar (300rpm)
for 72 hours at 37◦C to result in a visibly cloudy solution.
The production of Aβ(1∼40) aggregates was conﬁrmed by
a Jeol 100CX-transmission electron microscope (purchased
from JEOL USA, Inc.). Additional test for the formation of
Aβ(1∼40) aggregates was also performed using Thioﬂavine T
(2μM) by ﬂuorescence spectroscopy (excitation wavelength:
450 nm, scan range was from 460 to 600nm) [8]; there was
an obvious enhance of ﬂuorescence intensity of Thioﬂavine
T at the emission wavelength of 485nm when 5μLs o l u t i o n
of Aβ(1∼40) aggregates was added to the 500μLs o l u t i o no f
Thioﬂavine T (2μM) (Figure 1(b)). Aβ(1∼40) aggregates were
used immediately after preparation.
2.2. Syntheses and X-Ray Measurement. EHIDA (2,
2 -(2-(2,6-diethylphenylamino)-2-oxoethylazanediyl)diace-
tic acid) was synthesized according to the previous method
[6], and the structure of EHIDA has been conﬁrmed
by using melting point mensuration, IR, 1H-NMR,
13C-NMR, and Mass Spectrometry (data did not be
shown). 200μmol Re(CO)5Br reacted with the equimolar
EHIDA in the reﬂuxing mixture of 50mL ethanol and
0.1mL H2SO4 (4mol/L) for 48 hours, then the reaction
solution was washed by saturated NaHCO3 solution and
the target product was extracted by ethyl acetate, and
after evaporating the ethyl acetate, the yellowish solid
Table 2: Selected bond distances (˚ A) and bond angles (◦)f o rt h e
neutral complex: Re(CO)3(L).
Ligand Re(CO)3(L)
Re1-CCO 1.896 (7), 1.871 (6), 1.912 (6)
Re2-CCO 1.891 (7), 1.904 (7), 1.918 (7)
Re1-Ocarboxyl 2.115 (4), 2.160 (4)
Re2-Ocarboxyl 2.109 (4), 2.174 (4)
Re1-N 2.254 (4)
Re2-N 2.266 (4)
C(2)-Re(1)-C(1) 87.9 (3)
C(2)-Re(1)-C(3) 87.0 (3)
C(1)-Re(1)-C(3) 90.0 (3)
C(2)-Re(1)-O(4) 97.8 (2)
C(1)-Re(1)-O(4) 172.1 (2)
C(3)-Re(1)-O(4) 95.7 (2)
C(2)-Re(1)-O(6) 175.6 (2)
C(1)-Re(1)-O(6) 93.2 (2)
C(3)-Re(1)-O(6) 97.2 (2)
O(4)-Re(1)-O(6) 80.68 (15)
C(2)-Re(1)-N(1) 100.4 (2)
C(1)-Re(1)-N(1) 95.6 (2)
C(3)-Re(1)-N(1) 170.8 (2)
O(4)-Re(1)-N(1) 78.01 (15)
O(6)-Re(1)-N(1) 75.23 (14)
C(22)-Re(2)-C(23) 86.2 (3)
C(22)-Re(2)-C(24) 88.1 (3)
C(23)-Re(2)-C(24) 86.5 (3)
C(22)-Re(2)-O(12) 98.9 (2)
C(23)-Re(2)-O(12) 174.3 (2)
C(24)-Re(2)-O(12) 96.2 (2)
C(22)-Re(2)-O(14) 174.3 (2)
C(23)-Re(2)-O(14) 94.1 (2)
C(24)-Re(2)-O(14) 97.7 (2)
O(12)-Re(2)-O(14) 80.57 (15)
C(22)-Re(2)-N(3) 99.1 (2)
C(23)-Re(2)-N(3) 99.1 (2)
C(24)-Re(2)-N(3) 171.2 (2)
O(12)-Re(2)-N(3) 77.70 (15)
O(14)-Re(2)-N(3) 75.20 (15)
precipitated. The product was recrystallized in the mixture
of dichloromethane/ethanol (4 : 1) for one week to obtain
Re(CO)3(L) crystal. Results of X-ray measurement of
Re(CO)3(L) were obtained (Tables 1 and 2). IR (KBr): high
bands of CO (2036.6, 1922.3, 1903.0cm−1,v e r ys t r o n g )
and additional bands for the CO-group of the amide
(1633.0cm−1,s t r o n g ) ,C H 3 group (3062.9, 2969.3cm−1,
medium). TOF MS+ (m/z): 619.0880, 621.0872; calcd for
C21H25N2O185/187
8 Re, M = 619.0, 621.0.
The X-ray measurement of Re(CO)3(L) was carried
out on a CCD area X-ray detector. The Mo Kα radia-
tion (wavelength = 0.71073 ˚ A) was used. The data wereBioinorganic Chemistry and Applications 3
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Figure 1: (a) Observation of Aβ(1∼40) aggregates by transmissionelectron microscope (b) Formation of Aβ(1∼40) aggregates using Thioﬂavine
T by ﬂuorescence spectroscopy red line: ﬂuorescence intensity of the mixture of 5μLs o l u t i o no fA β(1∼40) aggregates and 500μL solution of
Thioﬂavine T (2μM); black line: ﬂuorescence intensity of 500μL solution of Thioﬂavine T (2μM) only.
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Figure 2: HPLC retention times of Re(CO)3(L) (a) and 99mTc(CO)3(EHIDA) (b).
collected by SADABS (Siemens Area Detector Absorption
correction program). The nonhydrogen atoms were reﬁned
anisotropically, whereas the hydrogen atoms were placed in
the calculated positions. The atomic scattering factors were
taken from [9, Tables 6.1.1.4 and 4.2.6.8]. Details of the X-
ray measurements and crystal data for Re(CO)3(L) are given
inTables1and2.Copiesofthedatacanbeobtainedonappli-
cation to CCDC, 12 Union Road, Cambridge CB2 1EZ, UK
(Fax: (+44) 1223-336-033; E-mail: deposit@ccdc.cam.ac.uk;
Internet: http://www.ccdc.cam.ac.uk/conts/retrieving.html).
The CCDC number of Re(CO)3(L) is 732731.
2.3. HPLC-UV Analysis and UV Visible of Re(CO)3(L) and
EHIDA. H P L C - U Va n a l y s i sw a sc a r r i e do u tw i t ha nA l l t i m a
RP C-18 column (250 × 4.6mm 2,5 μm) by using an Shi-
madzu System with SCL-10Avp HPLC pump system and UV
detector. The analysis gradient was (a): 0.1% triﬂuoroacetic
acid in water, (b): 0.1% triﬂuoroacetic acid in acetonitrile:
0 to 20 minutes, from 100% (a) to 100% (b); 20 to 30
minutes, 100% (b). The ﬂow rate was 0.9mL/min. The
excitation wavelength was 254nm. Results were displayed
in Figure 2. UV-visible absorption spectra of the ethanol
solution of Re(CO)3(L) and EHIDA were recorded, with
excitation wavelength scanning from 220 to 360nm at room
temperature. Results were in Figure 3.
2.4. Binding Aﬃnity to Aβ(1∼40) Aggregates by Fluorescence
Spectroscopy. Fresh solution of 0.1mM Re(CO)3(L) was
diluted to obtain a ﬁnal concentration range of 19 ∼
24μMR e ( C O ) 3(L) in 500μL PBS (pH 7.4). 5μLs o l u t i o n4 Bioinorganic Chemistry and Applications
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Figure 3: Ultraviolet Spectrum of the EHIDA (a) and Re(CO)3(L) (b).
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Figure 4: ORTEP drawing of the Re(CO)3(L).
of Aβ(1∼40) aggregates was added to 500μL PBS solution
of Re(CO)3(L) (the concentrations were 19, 20, 21, 22,
23, 24μM, resp.), and the mixed solution was incubated
for 1 minute at room temperature before measuring the
ﬂuorescence intensity (slit-width was 2nm). Excitation
wavelength was 320nm, and a 350 ∼ 600nm scan range
wasperformed.Allthedatawereperformedintriplicate.The
linear relationship between the concentrations (Re(CO)3(L)
only and Re(CO)3(L) incubated with Aβ(1∼40) aggregates)
and the integration of corresponding ﬂuorescence intensity
was analysed by Microcal Origin 6.0. Results were shown in
Figure 6.
3. Results and Discussion
3.1. Comparison of HPLC Analysis between Re(CO)3(L) and
99mTc(CO)3(EHIDA). The retention time of Re(CO)3(L)
(7.2minutes)wasnotsimilartothatof 99mTc(CO)3(EHIDA)
(18.0 minutes) [5] (shown in Figure 2), which is speculated
due to the change of lipophilicity of the ligand from EHIDA
to esteriﬁcation form. Esteriﬁed EHIDA (L) was more
lipophilic than EHIDA; so the retention times of Re(CO)3(L)
and 99mTc(CO)3(EHIDA) were diﬀerent; however, the diﬀer-
ence of properties of the Re(CO)3
+ core and 99mTc(CO)3
+
core may also lead to the diﬀerent retention times.Bioinorganic Chemistry and Applications 5
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Figure 5: Structures of Na/NEt4[Re(L2)(CO)3], NEt4[Re(L3)(CO)3][ 11]E H I D A ,L ,a n dR e ( C O ) 3(L).
3.2. UV Visible of Re(CO)3(L) and EHIDA. The UV-visible
absorption spectra of the complexes are illustrated in
Figure 3. Upon EHIDA, the visible intraligand (π-π∗) bands
at 240nm and 265nm were due to the fact that these two
bands are of mainly bpy-localized in nature. In comparison,
the additional visible MLCT (d-π∗)b a n do fR e ( C O ) 3(L) at
280nm was clearly associated with the coordinational –C=O
group on comparison with the UV spectra of the analogue
Re(I)(tricarbonyl)+ complexes [10] without the –CH2–C=O
group.
3.3. Description of the Structure of Re(CO)3(L): The neutral
crystalofRe(CO)3. Selected distances and bond angles of the
n e u t r a lc r y s t a lo fR e ( C O ) 3(L) are listed in Table 2, and the
molecular views are presented in Figure 4. From the ORTEP
drawing of the Re(CO)3(L), it can be known that there were
two diﬀerent structures of Re(CO)3(L) in one crystal cell.
The IDA derivatives often coordinate with Re/Tc(I)
(tricarbonyl)+ centers via classic coordination manner,
which is that each oxygen atom of the two carboxyl
groups and one N atom combine to the empty orbit in6 Bioinorganic Chemistry and Applications
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Figure 6: (a) The ﬂuorescence intensity of Re(CO)3(L) (20μM) (black line) and Re(CO)3(L) (20μM) incubated with Aβ(1∼40) aggregates
(red line) at the emission wavelength of 425nm. (b) Equation (1): the nether line and Equation (2): the upper line. (c) The ﬂuorescence
intensity of EHIDA (0.4mM) and emission wavelength (excitation wavelength is 280nm).
the rhenium or technetium [11], oppositely, our research
of the crystal structure of Re(CO)3(L) demonstrated that
oxygen atom of carbonyl has more stronger coordination
ability than the carboxyl group, so that an oxygen atom
in the carbonyl group, an oxygen atom in the carboxyl
group, and the N atom coordinated with the Re(CO)3
+
core in the molecular of Re(CO)3(L), and as a result,
2-((2-(2,6-diethylphenylamino)-2-oxoethyl)(2-ethoxy-2-
oxoethyl)amino)acetic acid (L or Esteriﬁed EHIDA) reacted
with Re(CO)5Br resulting in neutral but not negative
Re(CO)3(L) (Figure 5).
3.4. Studies on Binding Aβ(1∼40) Aggregates In Vitro. The
ﬂuorescence intensity of the mixture of Aβ(1∼40) aggre-
gates and Re(CO)3(L) can be signiﬁcantly stronger than
the ﬂuorescence intensity of Re(CO)3(L) only when the
concentration of Re(CO)3(L) was more than 19μM; for
example, when 500μLR e ( C O ) 3(L) (20μM) was added to
the solution of Aβ(1∼40) aggregates, there was an obvious
enhance of ﬂuorescence intensity at the emission wavelength
of 425nm (Figure 6(a)), oppositely, diﬀerent from the visible
ﬂuorescencespectroscopyofEHIDAat320nm(Figure 6(c)).
Upon excitation there occurs an intramolecular charge
transfer of Re(CO)3(L) between the –NH–C=Og r o u pa n d
rhenium, and then back charge transfer will be impossible.
Upon addition of Aβ(1∼40) aggregates, there was a visible
enhance of ﬂuorescence intensity at 425nm, with no disturb
of emission wavelength. Considering the breakage of the
system of conjugated bonds due to the reorientation of the
benzene ring and amide group of Re(CO)3(L) with respectBioinorganic Chemistry and Applications 7
to one another in PBS solution, the enhance of ﬂuorescence
intensity was mainly because of the breakage of the system of
conjugated bonds being inhabited by the microsurrounding
of β-amyloid aggregates when Aβ(1∼40) aggregates was added
[12]; as a result, an increased MLCT of Re(CO)3(L) then
occurred. However, the dissociation constant of Thioﬂavin
Te q u a l e d2μM[ 8], lower than that of Re(CO)3(L), because
of there is no obvious enhance of ﬂuorescence intensity
whentheconcentrationofRe(CO)3(L)waslittlethan19μM.
Generally, probes which bind characteristically to β-amyloid
fribilshavemorethanoneconjugationgsystemandelectron-
donating groups such as Me2N–, MeNH–, MeO–, and HO–
in their molecular skeletons [13], opposite to the structure
of Re(CO)3(L), indicative of a nonclassical intercalation
of the complex binding to the Aβ(1∼40) aggregates. The
rather good linear relationship between the concentrations
of Re(CO)3(L) and ﬂuorescence intensity (equation (1),
Figure 6(b)) was obtained by Microcal Origin 6.0:
Y =− 9.51095 ×107 +5 .53571 ×106X

R:0 .98151,SD: 2.2583 ×106,
N:6 ,P:5 .09878 ×10
−4
,
(1)
whereY istheﬂuorescenceintensity;X istheconcentrations,
from 19 to 24μM; R is the linear correlation coeﬃcient; SD
is the standard error.
When binding to β-amyloid aggregates, there was also
a great linear relationship between the concentrations
of Re(CO)3(L) and ﬂuorescence intensity (equation (2),
Figure 6(b)):
Y =− 9.74219 ×107 +5 .69714 ×106X

R:0 .98544,SD: 2.05598 ×106,
N:6 ,P:3 .16429 ×10
−4
,
(2)
where Y is the ﬂuorescence intensity; X is the concentrations
of Re(CO)3(L), from 19 to 24μM; R is the linear correlation
coeﬃcient; SD is the standard error.
4. Conclusion
In conclusion, the synthesis and X-ray measurement of
Re(CO)3(L) was successfully completed, providing a novel
crystal structure which was not similar to that of classical
Re/Tc(I)(tricarbonyl)+ IDA derivatives. Evaluation of its
binding aﬃnity to Aβ(1∼40) aggregates by the ﬂuorescence
method demonstrated that the binding characteristic was
at micromolar level, which suggested that the structural
modiﬁcation should be achieved for future exploration of
99mTc(CO)3
+ core labeled EHIDA derivatives as imaging
agents for Aβ(1∼40) plaques in vivo, and this work will
encourage for further exploration of probes for β-amyloid
plaques.
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